Strata Critical Medical, Inc. SRTA
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 68.38% | 66.75% | 29.62% | 2.73% | -17.86% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 68.38% | 66.75% | 29.62% | 2.73% | -17.86% |
| Cost of Revenue | 65.12% | 63.55% | 30.42% | 3.83% | -15.61% |
| Gross Profit | 82.24% | 80.73% | 26.49% | -1.62% | -26.23% |
| SG&A Expenses | 10.63% | -6.88% | -25.84% | -35.55% | -37.52% |
| Depreciation & Amortization | 580.13% | 448.02% | 188.72% | 196.66% | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 57.09% | 46.22% | 12.36% | -9.17% | -23.40% |
| Operating Income | 35.16% | 66.15% | 73.19% | 66.56% | 50.60% |
| Income Before Tax | 4.48% | -28.11% | 38.13% | 29.96% | 60.65% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 4.48% | -28.11% | 38.25% | 29.88% | 59.90% |
| Earnings from Discontinued Operations | -105.91% | 7,103.31% | 11,141.33% | 4,588.02% | 1,601.47% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -161.43% | 311.88% | 276.90% | 251.42% | 178.49% |
| EBIT | 35.16% | 66.15% | 73.19% | 66.56% | 50.60% |
| EBITDA | 156.11% | 128.08% | 97.37% | 81.32% | 55.97% |
| EPS Basic | -159.64% | 306.85% | 268.35% | 242.90% | 170.79% |
| Normalized Basic EPS | 48.82% | 79.15% | 78.01% | 72.27% | 7.61% |
| EPS Diluted | -161.34% | 301.89% | 263.38% | 237.15% | 168.88% |
| Normalized Diluted EPS | 48.82% | 79.15% | 78.01% | 72.27% | 7.61% |
| Average Basic Shares Outstanding | 6.93% | 6.58% | 6.27% | 5.92% | 5.22% |
| Average Diluted Shares Outstanding | 8.43% | 8.11% | 7.81% | 5.92% | 5.22% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |